Mouse models of respiratory inflammation have been indispensable to the dissection of immune pathways that result in lung remodeling and dysfunction. The value of these models results not only from their ability to represent the inflammation occurring in human disease but also from their usefulness in reductionist approaches examining specific cells and/or inflammatory pathways. Previous attempts using mice to examine the role of eosinophils in respiratory inflammation have been limited by the nominal character of disease pathology occurring in these models (i.e., the observed pathologies are only a subset of those occurring in humans) as well as differences observed between eosinophil activities occurring in the lungs of asthma patients and those in the established mouse models (i.e., eosinophils in these models displayed little evidence of granule protein release (i.e., degranulation)). These limitations have led us to create an allergen- naive double transgenic mouse (I5/hE2) that expresses IL-5 systemically from mature T cells and eotaxin-2 locally from lung epithelial cells. I5/hE2 mice develop many pulmonary pathologies that were absent in earlier mouse models but which nonetheless occur in severe asthma patients. More importantly, extensive eosinophil degranulation in the lung (previously only associated with asthma patients) accompanies the pathologies in the I5/hE2 model. In addition, we have demonstrated that all of the pathologies in I5/hE2 mice are absolutely dependent on the induced pulmonary eosinophilia. This proposal capitalizes on the availability of the I5/hE2 transgenic model as well as our unique eosinophil-less line of mice (PHIL) to test the central hypothesis that eosinophils themselves are the relevant source of the molecules commonly suggested to be responsible for remodeling and airway dysfunction. The objectives of the proposal will be achieved using these mice and other novel eosinophil-specific reagents/methodologies by the completion of the following Specific Aims: (1) To determine if immunoregulation of the pulmonary microenvironment by eosinophils contributes to inflammatory responses leading to pulmonary pathologies;(2) To demonstrate that eosinophil- derived TGF-?1 activities directly contribute to pulmonary remodeling events and lung dysfunction;(3) To define the pulmonary remodeling events, including induced lung dysfunction, mediated by the release of eosinophil granule proteins.

Public Health Relevance

The scientific literature abounds with studies which question whether the recruitment to the lung of a unique white blood cell, the eosinophil, contributes to the development of asthma. Clearly, these conflicting reports suggest that the importance of eosinophils is not fully understood. Our development of a novel mouse asthma model replicating the hallmark features of this disease provides a unique ability to understand the roles of eosinophils in lung inflammation and an invaluable resource for the development of therapeutic strategies.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Lung Cellular, Molecular, and Immunobiology Study Section (LCMI)
Program Officer
Noel, Patricia
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Mayo Clinic, Arizona
United States
Zip Code
Jacobsen, E A; Lee, N A; Lee, J J (2014) Re-defining the unique roles for eosinophils in allergic respiratory inflammation. Clin Exp Allergy 44:1119-36
Jacobsen, E A; Lesuer, W E; Willetts, L et al. (2014) Eosinophil activities modulate the immune/inflammatory character of allergic respiratory responses in mice. Allergy 69:315-27
Furuta, Glenn T; Atkins, F Dan; Lee, Nancy A et al. (2014) Changing roles of eosinophils in health and disease. Ann Allergy Asthma Immunol 113:3-8
Percopo, Caroline M; Dyer, Kimberly D; Ochkur, Sergei I et al. (2014) Activated mouse eosinophils protect against lethal respiratory virus infection. Blood 123:743-52
Nair, P; Ochkur, S I; Protheroe, C et al. (2013) Eosinophil peroxidase in sputum represents a unique biomarker of airway eosinophilia. Allergy 68:1177-84
Doyle, Alfred D; Jacobsen, Elizabeth A; Ochkur, Sergei I et al. (2013) Homologous recombination into the eosinophil peroxidase locus generates a strain of mice expressing Cre recombinase exclusively in eosinophils. J Leukoc Biol 94:17-24
Doyle, Alfred D; Jacobsen, Elizabeth A; Ochkur, Sergei I et al. (2013) Expression of the secondary granule proteins major basic protein 1 (MBP-1) and eosinophil peroxidase (EPX) is required for eosinophilopoiesis in mice. Blood 122:781-90
Ochkur, Sergei I; Kim, John Dongil; Protheroe, Cheryl A et al. (2012) The development of a sensitive and specific ELISA for mouse eosinophil peroxidase: assessment of eosinophil degranulation ex vivo and in models of human disease. J Immunol Methods 375:138-47
Doyle, Alfred; McGarry, Michael P; Lee, Nancy A et al. (2012) The construction of transgenic and gene knockout/knockin mouse models of human disease. Transgenic Res 21:327-49
Willetts, Lian; Parker, Kimberly; Wesselius, Lewis J et al. (2011) Immunodetection of occult eosinophils in lung tissue biopsies may help predict survival in acute lung injury. Respir Res 12:116

Showing the most recent 10 out of 28 publications